Test of Novel Drug for Smoking Cessation

Summary

The study will assess a novel active drug vs. placebo on ability to reduce smoking and aid cessation during a one-week "practice" quit period for each condition in smokers with a high interest in quitting (i.e. crossover design). Medication effects on reducing withdrawal and cognitive impairment will help assess the mechanism to support quit smoking attempts.

Timeline

Start

2014-11

Primary completion

2017-07

Completion

2018-01

Drugs

Indications

No indication recorded.